Vapogenix, Inc. — Form D/A
Vapogenix, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2016-12-08. The offering totals $8.6M, of which $8.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-12-08
- Form: D/A
- Accession: 0001628848-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.6M
- Amount sold: $8.2M
- Remaining: $410K
- Minimum investment: $20K
- Investors: 37
- Date of first sale: 2016-08-31
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-270590
Issuer
- Name: Vapogenix, Inc.
- CIK: 0001628848
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 8285 EL RIO ST., SUITE 170, HOUSTON, TX, 77054
- Phone: 713-748-3903 X224
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Danguole Altman | Director | Houston, TX |
| Danguole Altman | Executive Officer | Houston, TX |
| Marc Loev | Director | Plantation, FL |
| Clay M Heighten | Director | Dallas, TX |
| Bruce Given | Director | Houston, TX |
| George Davitt | Director | Houston, TX |
| Christopher Jorgensen | Director | Houston, TX |
| Motter Clarice | Executive Officer | Houston, TX |
| Christopher Jorgeson | Director | Houston, TX |
| Danguole Spakevicius | Director | Houston, TX |
| Danguole Spakevicius | Executive Officer | Houston, TX |
Other filings by this issuer (3)
More